- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1UI: 4-[(3S)-3-cyano-3-cyclopropyl-2-oxidanylidene-pyrrolidin-1-yl]-N-[[3-fluoranyl-5-(5-methoxypyridin-3-yl)phenyl]methyl]-6-methyl-pyridine-2-carboxamide(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
ZN.2: 4 residues within 4Å:- Chain A: C.441, C.446, C.488, C.490
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.441, A:C.446, A:C.488, A:C.490
ZN.10: 4 residues within 4Å:- Chain B: C.441, C.446, C.488, C.490
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.441, B:C.446, B:C.488, B:C.490
- 6 x CA: CALCIUM ION(Non-covalent)
CA.3: 2 residues within 4Å:- Chain A: S.369, Q.371
No protein-ligand interaction detected (PLIP)CA.6: 2 residues within 4Å:- Chain A: D.89, E.93
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.89, A:E.93, H2O.1, H2O.4
CA.7: 1 residues within 4Å:- Chain A: D.19
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:D.19
CA.11: 2 residues within 4Å:- Chain B: D.89, E.93
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.89, B:E.93, H2O.7, H2O.7
CA.12: 1 residues within 4Å:- Chain B: D.213
No protein-ligand interaction detected (PLIP)CA.14: 1 residues within 4Å:- Chain B: G.256
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:G.256
- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.4: 3 residues within 4Å:- Chain A: K.200, F.476, K.477
Ligand excluded by PLIPCL.5: 3 residues within 4Å:- Chain A: L.105, A.106
- Chain B: W.146
Ligand excluded by PLIPCL.13: 4 residues within 4Å:- Chain B: R.335, A.336, L.338, R.339
Ligand excluded by PLIPCL.15: 4 residues within 4Å:- Chain B: L.17, A.18, Q.152, M.278
Ligand excluded by PLIP- 2 x PRO: PROLINE(Non-covalent)
PRO.8: 13 residues within 4Å:- Chain A: T.114, E.116, R.145, W.162, E.164, H.166, F.209, T.233, H.235, S.265, W.266, G.267
- Ligands: 1UI.1
11 PLIP interactions:9 interactions with chain A, 2 Ligand-Ligand interactions- Hydrophobic interactions: A:W.162, A:E.164
- Hydrogen bonds: A:T.114, A:T.114, A:S.265, P.8, P.8
- Water bridges: A:R.145, A:R.145
- Salt bridges: A:R.145, A:H.235
PRO.16: 13 residues within 4Å:- Chain B: T.114, E.116, R.145, W.162, E.164, H.166, F.209, T.233, H.235, S.265, W.266, G.267
- Ligands: 1UI.9
9 PLIP interactions:1 Ligand-Ligand interactions, 8 interactions with chain B- Hydrogen bonds: P.16, B:T.114, B:S.265
- Hydrophobic interactions: B:W.162, B:E.164
- Water bridges: B:R.145, B:R.145
- Salt bridges: B:R.145, B:H.235
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yogavel, M. et al., Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis. Plos Pathog. (2023)
- Release Date
- 2022-07-06
- Peptides
- Bifunctional glutamate/proline--tRNA ligase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1UI: 4-[(3S)-3-cyano-3-cyclopropyl-2-oxidanylidene-pyrrolidin-1-yl]-N-[[3-fluoranyl-5-(5-methoxypyridin-3-yl)phenyl]methyl]-6-methyl-pyridine-2-carboxamide(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- 6 x CA: CALCIUM ION(Non-covalent)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x PRO: PROLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yogavel, M. et al., Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis. Plos Pathog. (2023)
- Release Date
- 2022-07-06
- Peptides
- Bifunctional glutamate/proline--tRNA ligase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B